NARA Discovery
Article Details
← Back to Search Results
Journal Article

Development and application of a sensitive droplet digital PCR ‐based method to detect tilapia parvovirus

Haikuo Zhao; Yong Zhou; Yuding Fan; Nan Jiang; Yan Meng; Yiqun Li; Mingyang Xue; Chen Xu; Weiliang Guo; Wenzhi Liu
Journal of Fish Diseases · Vol. 46, Issue 3 · pp. 239-245 · 2023

Abstract

Tilapia parvovirus (TiPV) causes severe mortality rates in cultured tilapia, resulting in substantial losses to the fish industry. Droplet digital PCR (ddPCR) is a sensitive, accurate, and absolute quantitation method, plus it does not require a standard curve. Herein we report the development and application of a sensitive ddPCR‐based method to rapidly detect and quantify TiPV. Optimal annealing temperature was determined to be 59.3°C, and optimal primer and probe concentrations were 900 nmol/L and 250 nmol/L, respectively. Our ddPCR method was highly specific to TiPV and showed no cross‐reactivity with other viruses. Further, the detection limit of ddPCR was 0.07 copies/μl, being lower than that of real‐time PCR (qPCR, 4.63 copies/μl). We also investigated the ability of ddPCR to detect TiPV in 50 samples and compared the outcome with qPCR data in terms of sensitivity and accuracy. The results showed that the positive detection rate of ddPCR (32%) was higher than that of qPCR (18%). To conclude, our ddPCR method was effective at detecting TiPV in samples with low viral loads. We believe that its application can facilitate the surveillance of sources and transmission routes of TiPV.

Bibliographic Information

JournalJournal of Fish Diseases
PublisherWiley
Publication Date2023-03-01
Publication Year2023
Volume46
Issue3
Pages239-245
Document TypeJournal Article
Print ISSN0140-7775
eISSN1365-2761
DOI10.1111/jfd.13738
SubjectGeneral Aquaculture, Fisheries & Fish Science

Access Information

NARA Access Coverage1997-01-01~Current
Journal Homepagehttps://onlinelibrary.wiley.com/loi/13652761
Publisher PageOpen Publisher Page
Full-text access depends on NARA's subscribed coverage and institutional access.